"Balancing Medical Promise and Regulatory Complexity in the Psychedelics Landscape"

The "Psychedelics Capital Podcast" host Ross O'Brien  from Bonaventure Equity interviews Michael Werner from Holland & Knight, discussing the regulatory landscape for psychedelics. Michael, a partner at the law firm, explains that while the FDA sees itself as a public health agency focused on ensuring safe and effective products, the DEA approaches controlled substances like psychedelics from a law enforcement perspective due to their potential dangers. He highlights that while many drugs, including psychedelics, have potential benefits, the FDA emphasizes the importance of rigorous clinical trials to establish their safety and efficacy, particularly in a landscape where recreational and unregulated use is also prevalent.

Produced by PodConx

Ross O'Brien -  https://www.linkedin.com/in/rossobrien/

Bonaventure Equity - https://link.bve.vc/Visit-Us

Michael Warner - https://www.linkedin.com/in/michael-werner-a402189/

Holland & Knight - https://www.hklaw.com/

Exploring the Potential of Psychedelics and Natural Compounds

Dick Simon, the founder of Sensorium Therapeutics, discusses his journey and motivation in the field of psychedelics. Inspired by a friend's success with psychedelics in treating mental health issues, Dick embarked on a mission to advance research and de-stigmatization. He he joins Ross O'Brien  from Bonaventure Equity to talk about  co-founding Sensorium to create novel pharmaceuticals using a comprehensive database of psychoactive plants and fungi, leveraging artificial intelligence and machine learning for drug discovery. The company aims to have a significant impact in mental health and provide alternative treatment options for those who may not benefit from traditional psychedelics therapies.

Produced by PodConx

Ross O'Brien -  https://www.linkedin.com/in/rossobrien/

Bonaventure Equity - https://link.bve.vc/Visit-Us

Dick Simons - https://www.linkedin.com/in/dick-simon-6050ba5/

Sensorium Therapeutics - https://www.sensorium.bio/

Jennifer Fisher and Bill Growney, two partners at Goodwin Proctor, a law firm specializing in the cannabis industry join Ross O'Brien  from Bonaventure Equity to talk about their practice and their work advising companies in the cannabis and psychedelic spaces. The conversation covers topics such as regulatory compliance, legal challenges, and unique challenges faced by emerging companies in these industries.

Produced by PodConX

Ross O'Brien -  https://www.linkedin.com/in/rossobrien/

Bonaventure Equity - https://link.bve.vc/Visit-Us

Jennifer Fisher - https://www.linkedin.com/in/jennifer-briggs-fisher-14843a/

Bill Growney - https://www.linkedin.com/in/billgrowney/

Goodwin Proctor - https://www.goodwinlaw.com/en